Anúncio
Anúncio

PFE

PFE logo

Pfizer Inc.

24.90
USD
Patrocinado
-0.09
-0.38%
31 de dez., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

24.89

0.00
0.00%

Relatórios de Lucros PFE

Rácio de surpresa positiva

PFE separação 34 de 39 últimas estimativas.

87%

Próximo Relatório

Data do Próximo Relatório
02 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$17.29B
/
$0.57
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+3.83%
/
-34.48%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-2.65%
/
-9.52%

Pfizer Inc. earnings per share and revenue

On 04 de nov. de 2025, PFE reported earnings of 0.87 USD per share (EPS) for Q3 25, beating the estimate of 0.63 USD, resulting in a 36.00% surprise. Revenue reached 16.65 bilhão, compared to an expected 16.74 bilhão, with a -0.53% difference. The market reacted with a -1.46% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 18 analistas forecast an EPS of 0.57 USD, with revenue projected to reach 17.29 bilhão USD, implying an diminuir of -34.48% EPS, and aumentar of 3.83% in Revenue from the last quarter.
FAQ
For Q3 2025, Pfizer Inc. reported EPS of $0.87, beating estimates by 36%, and revenue of $16.65B, -0.53% below expectations.
The stock price moved down -1.46%, changed from $24.66 before the earnings release to $24.30 the day after.
The next earning report is scheduled for 02 de fev. de 2026.
Based on 18 analistas, Pfizer Inc. is expected to report EPS of $0.57 and revenue of $17.29B for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio